AML: CA 27.29 (Cancer Antigen)

The CA 27.29 test measures a cancer antigen in the blood, primarily used to monitor breast cancer in those already diagnosed. It helps assess treatment effectiveness and disease progression. Elevated levels may indicate cancer cell presence, while decreasing levels suggest positive treatment response. This test is important, when experiencing:   

• Breast lumps

• Changes in breast shape or size

• Skin alterations on the breast

• Nipple discharge

• Pain

It assists in comprehensive breast cancer management.